Voxelotor, a promising new drug for sickle cell disease, will be made available to patients in england, aiming to reduce hospital visits and improve life quality.
The UK government has unveiled a fast-tracked registration process for dentists trained abroad to combat a severe shortage and decline in NHS dental access